AbbVie increased its Research and Development expenses by 20% year-over-year to $2.47 billion, signaling a major investment to advance all stages of its pipeline assets. This creates a need for tools and services supporting clinical trials, data management, and research operations.
Filing excerpt
Research and development (R&D) expenses as a percentage of net revenues increased for the three months ended March 31, 2026 compared to the prior year primarily due to increased funding to support all stages of the company’s pipeline assets.
What this signalsFilings often name leadership changes, deals and spending plans.
sec-10qcapexIncreaseGet every 10-Q signal for AbbVie and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at AbbVie this week?”
The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/9f7666a1-b290-4f29-8a59-2287618415bf returns this record as JSON. POST /v1/companies/enrich returns every signal for abbvie.com.
{
"signal_id": "9f7666a1-b290-4f29-8a59-2287618415bf",
"signal_type": "sec-10q",
"signal_subtype": "capexIncrease",
"detected_at": "2026-05-12T09:24:57.857+00:00",
"company": {
"name": "AbbVie",
"domain": "abbvie.com"
},
"data": {
"detail": "AbbVie increased its Research and Development expenses by 20% year-over-year to $2.47 billion, signaling a major investment to advance all stages of its pipeline assets. This creates a need for tools and services supporting clinical trials, data management, and research operations.",
"metrics": {
"pct": 20,
"timeframe": "current_quarter",
"pct_context": "YoY increase in R&D expenses",
"dollar_context": "R&D expenses for Q1 2026",
"dollar_millions": 2472
},
"summary": "R&D spending increased 20% to $2.5B to support drug pipeline development",
"excerpts": "Research and development (R&D) expenses as a percentage of net revenues increased for the three months ended March 31, 2026 compared to the prior year primarily due to increased funding to support all stages of the company’s pipeline assets.",
"relevance": 0.8,
"sentiment": "positive",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/1551152/000155115226000017/abbv-20260331.htm",
"filing_date": "2026-05-08",
"filing_year": 2026,
"fiscal_year": 0,
"fiscal_year_end": "03/31",
"sales_relevance": "Budget available",
"signal_category": "financial"
}
}
curl https://signals.autobound.ai/v1/signals/9f7666a1-b290-4f29-8a59-2287618415bf \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"abbvie.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.